You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

analytical treatment interruption

Showing 1 - 25 of 945
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)

Withdrawn
  • HIV Infection
  • Analytical Treatment Interruption + bNAbs infusion
  • Milan, Lombardy, Italy
  • +3 more
Aug 2, 2022

HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

Recruiting
  • HIV Infection
  • Analytical Treatment Interruption
  • Los Angeles, California
  • +11 more
Jan 13, 2023

HIV Infection Trial in Worldwide (Analytical Treatment Interruption)

Recruiting
  • HIV Infection
  • Analytical Treatment Interruption
  • Gaborone, Botswana
  • +10 more
May 16, 2022

Human Immunodeficiency Virus Trial in Boston, New York (3BNC117, 10-1074, Analytical treatment interruption)

Completed
  • Human Immunodeficiency Virus
  • Boston, Massachusetts
  • +1 more
Feb 11, 2022

Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

Not yet recruiting
  • Human Immuno-deficiency Virus (HIV) Disease
  • (no location specified)
Sep 5, 2023

HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

Not yet recruiting
  • HIV-1-infection
  • Molepolole, Botswana
  • +8 more
Sep 8, 2023

Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)

Not yet recruiting
  • Chronic HIV Infection
  • 426c.Mod.Core-C4b
  • Adjuvant 3M-052-AF+Alum
  • Birmingham, Alabama
  • +6 more
Aug 17, 2023

Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

Not yet recruiting
  • Human Immunodeficiency Virus
  • New York, New York
  • +2 more
Jul 12, 2022

HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

Suspended
  • HIV Infections
  • Birmingham, Alabama
  • +5 more
Jan 31, 2023

HIV Trial in France (Analytical Treatment Interruption (ATI))

Not yet recruiting
  • HIV Infections
  • Analytical Treatment Interruption (ATI)
  • Aix-en-Provence, France
  • +29 more
Jul 28, 2022

HIV Trial in Birmingham, Philadelphia (VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Birmingham, Alabama
  • +1 more
Oct 15, 2021

HIV/AIDS Trial in Beijing (Albuvirtide, 3BNC117)

Not yet recruiting
  • HIV/AIDS
  • Beijing, China
    Peking Union Medical College Hospital
Mar 24, 2021

HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

Unknown status
  • HIV
  • +2 more
  • Pegylated Interferon alpha 2b (peg-IFN-α2b)
  • 3BNC117 + 10-1074
  • Philadelphia, Pennsylvania
  • +1 more
Jun 22, 2021

HIV-1 Infection Trial in New York (3BNC117, ART Interruption)

Completed
Has Results
  • HIV-1 Infection
  • New York, New York
    The Rockefeller University
Jul 8, 2020

HIV Trial run by the NIAID (Entyvio (Vedolizumab))

Completed
Has Results
  • HIV
  • Entyvio (Vedolizumab)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 19, 2020

Interruption and Re-Initiation of Antiretroviral Therapy on

Completed
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 16, 2020

    HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1

    Not yet recruiting
    • HIV Vaccine
    • Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
    • +2 more
    • São Paulo, Brazil
      Hospital das Clínicas da Faculdade de Medicina da USP
    Mar 14, 2023

    HIV-1 Infection Trial in Antwerp, Brussels, Ghent (ART interruption)

    Completed
    Has Results
    • HIV-1 Infection
    • ART interruption
    • Antwerp, Belgium
    • +3 more
    Sep 23, 2019

    HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

    Recruiting
    • HIV-1-infection
    • Umlazi, South Africa
      FRESH Clinical Research Site: Females Rising through Education,
    Jan 4, 2023

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    DOAC in Chinese Patients With Atrial Fibrillation

    Recruiting
    • Atrial Fibrillation
    • +6 more
    • Blood Tests
    • Hong Kong, Hong Kong
      Chinese University of Hong Kong
    Oct 11, 2022

    Human Immunodeficiency Virus (HIV) Trial in New York, Aarhus, Cologne (3BNC117, Romidepsin)

    Completed
    • Human Immunodeficiency Virus (HIV)
    • New York, New York
    • +2 more
    Feb 3, 2021

    HIV Trial run by the NIAID (VRC-HIVMAB060-00-AB (VRC01), 10-1074, Normal Saline Placebo)

    Terminated
    Has Results
    • HIV
    • VRC-HIVMAB060-00-AB (VRC01)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Sep 22, 2021

    HIV Trial (HIV-1 Immunogen, Structured Treatment Interruption)

    Withdrawn
    • HIV Infections
    • HIV-1 Immunogen
    • Structured Treatment Interruption
    • (no location specified)
    Oct 28, 2021

    Dose Reduction and Discontinuation With Anti-Fibrotic

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Ridgefield, Connecticut
      Boehringer Ingelheim
    Mar 24, 2023